Reversal of Borrelia Burgdorferi Associated Dilated Cardiomyopathy by Antibiotic Treatment?

Overview

Journal Cardiovasc Drugs Ther

Specialties Cardiology & Vascular Diseases
Pharmacology

Date 1996 Jul 1

PMID 8877079

Citations 2

Authors

R Gasser

F Fruhwald

M Schumacher

G Seinost

E Reisinger

B Eber

A Keplinger

R Horvath

B Sedaj

W Klein

K Pierer

Affiliations

Soon will be listed here.

Abstract

It is suggested that Borrelia burgdorferi infection could be associated with dilated cardiomyopathy (IDC). Stanek et al. were able to cultivate Borrelia burgdorferi from myocardial biopsy tissue of a patient with longstanding dilated cardiomyopathy. Here we present a study in which we examined the effect of standard antibiotic treatment on the left ventricular ejection fraction (LVEF) in patients with dilated cardiomyopathy associated with Borrelia burgdorferi infection. In this study we assessed the serum (IgG, IgM Elisa) and history of 46 IDC patients with specific regard to Borrelia burgdorferi infection (mean LVEF 30.4 +/- 1.3%, measured by cardiac catheterization and echocardiography with the length-area-volume method). All 46 patients received standard treatment for dilated cardiomyopathy: ACE inhibitors, digitalis, and diuretics. Eleven (24%) patients showed positive serology and a history of Borrelia burgdorferi infection; nine of these also had a typical history of tick bite and erythema chronicum migrans (ECM) and/or other organ involvement, and two had no recollection of tick bite or ECM but showed other Borrelia burgdorferi-associated disorders (neuropathy, oligoarthritis). These 11 patients with Borrelia burgdorferi infection received standard antibiotic treatment with intravenous ceftriaxone 2 g bid for 14 days. Six (55%) recovered completely and showed a normal LVEF after 6 months, three (27%) improved their LVEF, and two (18%) did not improve at all. This amounts to nine (82%) patients with recovery/improvement in the Borrelia burgdorferi group. The 35 patients who did not show positive serology or a history of Borrelia burgdorferi infection did not receive antibiotic treatment. In this group without Borrelia burgdorferi infection 12 (26%), showed recovery/improvement following the standard treatment of dilated cardiomyopathy (see earlier). Our results indicate that Borrelia burgdorferi infection could play a decisive role in the development of dilated cardiomyopathy, especially in a geographical region such as Graz, where Borrelia burgdorferi is endemic. While we are aware of the small number of Borrelia burgdorferi patients in this study, we nevertheless conclude that in a remarkable number of patients with signs of Borrelia burgdorferi infection, dilated cardiomyopathy could be reversed and LVEF improved.

Citing Articles

Suspected inflammatory cardiomyopathy. Prevalence of Borrelia burgdorferi in endomyocardial biopsies with positive serological evidence.

Karatolios K, Maisch B, Pankuweit S Herz. 2014; 40 Suppl 1:91-5.

PMID: 24938220 DOI: 10.1007/s00059-014-4118-x.

Update on Lyme Carditis.

Bateman , Sigal Curr Infect Dis Rep. 2000; 2(4):299-301.

PMID: 11095868 DOI: 10.1007/s11908-000-0006-z.

References

Dattwyler R, Halperin J, Pass H, Luft B . Ceftriaxone as effective therapy in refractory Lyme disease. J Infect Dis. 1987; 155(6):1322-5. DOI: 10.1093/infdis/155.6.1322. View

Gillum R . Idiopathic cardiomyopathy in the United States, 1970-1982. Am Heart J. 1986; 111(4):752-5. DOI: 10.1016/0002-8703(86)90111-0. View

Johnson R, Kodner C, Russell M . In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents. Antimicrob Agents Chemother. 1987; 31(2):164-7. PMC: 174684. DOI: 10.1128/AAC.31.2.164. View

Corpuz M, Hilton E, LARDIS M, Singer C, Zolan J . Problems in the use of serologic tests for the diagnosis of Lyme disease. Arch Intern Med. 1991; 151(9):1837-40. View

Vlay S, Dervan J, Elias J, Kane P, Dattwyler R . Ventricular tachycardia associated with Lyme carditis. Am Heart J. 1991; 121(5):1558-60. DOI: 10.1016/0002-8703(91)90173-f. View

. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J. 1980; 44(6):672-3. PMC: 482464. DOI: 10.1136/hrt.44.6.672. View

Erbel R, Schweizer P, Lambertz H, Henn G, Meyer J, Krebs W . Echoventriculography -- a simultaneous analysis of two-dimensional echocardiography and cineventriculography. Circulation. 1983; 67(1):205-15. DOI: 10.1161/01.cir.67.1.205. View

BURGDORFER W . Lyme borreliosis: ten years after discovery of the etiologic agent, Borrelia burgdorferi. Infection. 1991; 19(4):257-62. DOI: 10.1007/BF01644963. View

Steere A, Hutchinson G, Rahn D, Sigal L, Craft J, DeSanna E . Treatment of the early manifestations of Lyme disease. Ann Intern Med. 1983; 99(1):22-6. DOI: 10.7326/0003-4819-99-1-22. View

10.

Klein J, Stanek G, Bittner R, Horvat R, Holzinger C, Glogar D . Lyme borreliosis as a cause of myocarditis and heart muscle disease. Eur Heart J. 1991; 12 Suppl D:73-5. DOI: 10.1093/eurheartj/12.suppl_d.73. View

11.

Fuster V, Gersh B, GIULIANI E, Tajik A, BRANDENBURG R, Frye R . The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981; 47(3):525-31. DOI: 10.1016/0002-9149(81)90534-8. View

12.

Goodman J, Jurkovich P, Kodner C, Johnson R . Persistent cardiac and urinary tract infections with Borrelia burgdorferi in experimentally infected Syrian hamsters. J Clin Microbiol. 1991; 29(5):894-6. PMC: 269903. DOI: 10.1128/jcm.29.5.894-896.1991. View

13.

Yuk J, Nightingale C, Quintiliani R . Clinical pharmacokinetics of ceftriaxone. Clin Pharmacokinet. 1989; 17(4):223-35. DOI: 10.2165/00003088-198917040-00002. View

14.

Guerrero A, Quereda C, Escudero R, Cobo J, Morcillo R, Marti-Belda P . [Serologic diagnosis of Lyme disease. A pending problem]. Enferm Infecc Microbiol Clin. 1991; 9(6):335-8. View

15.

Kaell A, Volkman D, Gorevic P, Dattwyler R . Positive Lyme serology in subacute bacterial endocarditis. A study of four patients. JAMA. 1990; 264(22):2916-8. View

16.

Steere A, Grodzicki R, Kornblatt A, Craft J, Barbour A, BURGDORFER W . The spirochetal etiology of Lyme disease. N Engl J Med. 1983; 308(13):733-40. DOI: 10.1056/NEJM198303313081301. View

17.

Schwan T, Karstens R, Schrumpf M, Simpson W . Changes in antigenic reactivity of Borrelia burgdorferi, the Lyme disease spirochete, during persistent infection in mice. Can J Microbiol. 1991; 37(6):450-4. DOI: 10.1139/m91-074. View

18.

Stanek G, Klein J, Bittner R, Glogar D . Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med. 1990; 322(4):249-52. DOI: 10.1056/NEJM199001253220407. View

19.

Wunderlich E, Graf A, Thess G, Foelske H . [Dilated myocardial disease as sequela of chronic Lyme carditis]. Z Kardiol. 1990; 79(8):599-600. View

20.

McAlister H, Klementowicz P, Andrews C, Fisher J, Feld M, Furman S . Lyme carditis: an important cause of reversible heart block. Ann Intern Med. 1989; 110(5):339-45. DOI: 10.7326/0003-4819-110-5-339. View